Kseniya Maslova

T-cadherin attenuates insulin-dependent signalling, eNOS activation, and angiogenesis in vascular endothelial cells

Maria Philippova, Manjunath B. Joshi, Dennis Pfaff et al. · Cardiovascular Research · 2012 · 47 citations · Full text

Life Sciences, Biochemistry, Endocrinology +17

T-Cadherin Is an Auxiliary Negative Regulator of EGFR Pathway Activity in Cutaneous Squamous Cell Carcinoma: Impact on Cell Motility

Emmanouil Kyriakakis, Kseniya Maslova, Maria Philippova et al. · Journal of Investigative Dermatology · 2012 · 28 citations · Full text

Medicine, Cancer Biology, Oncology +12

T-cadherin loss induces an invasive phenotype in human keratinocytes and squamous cell carcinoma (SCC) cells<i>in vitro</i>and is associated with malignant transformation of cutaneous SCC<i>in vivo</i>

Dennis Pfaff, Maria Philippova, Stanislaw A. Buechner et al. · British Journal of Dermatology · 2010 · 26 citations

Medicine, Cell Biology, Dermatology +11

Novel Antibody Drug Conjugates Targeting Tumor-Associated Receptor Tyrosine Kinase ROR2 by Functional Screening of Fully Human Antibody Libraries Using Transpo-mAb Display on Progenitor B Cells

Ina Hellmann, Lorenz Waldmeier, Marie-Christine Bannwarth-Escher et al. · Frontiers in Immunology · 2018 · 25 citations · Full text

Pharmacy, Immunology, Oncology +17

EGFR and IGF‐1R in regulation of prostate cancer cell phenotype and polarity: opposing functions and modulation by T‐cadherin

Kseniya Maslova, Emmanouil Kyriakakis, Dennis Pfaff et al. · The FASEB Journal · 2014 · 20 citations

Life Sciences, Cell Biology, Molecular Biology +17